FMCG, healthcare stocks defy markets with spirited fight back, gain up to 4%

As Sensex and Nifty tanked nearly 4% on Tuesday in the wake of early poll trends, FMCG and healthcare sectors held strong, with Nifty FMCG, Nifty Pharma performing well. Dabur India, Colgate Palmolive, and Marico were top gainers.

Even as the headline indices S&P BSE and tanked nearly 4% to the day's low of 73,659.29 and 22,389.85 respectively on Tuesday, with early trends suggesting a fightback by the India alliance albeit a majority mark for the NDA alliance, certain sectors managed to hold themselves as others witnessed a free fall.

While slipped from Monday's closing of 76,468.78 by 2809 points on the intraday basis, the broader witnessed an 874 point fall to 23,263.90.

The sectors which defied the trends were and healthcare, with , and gaining 0.23%, 0.40% and 0.60%, respectively around 10:40 am.

The Nifty FMCG was trading at 54,606.85, down by 46.75 points or 0.09% with 11 stocks trading in the green around this time while the rest 4 were in the red. The top gainers were , and Marico which were up by up to 4% while the losers in the pack were Balrampur Chini, Radico Khaitan, Varun Beverages and which fell between 4% and 0.76%.

Meanwhile, Nifty Healthcare was marginally up with over 6 points lead and traded at 11,854.15. There were 8 advances and 12 declines in a 20-stock index. The gainers were Max Healthcare, Divi's Laboratories and Abbott India. They were up by 2%, 1% and 0.84%, respectively. The laggards were Glenmark Pharma, Granules India, Biocon and Alkem Laboratories which declined by up to 4.21%.

Nifty Pharma which fought against the trends in early trade also fell by 0.40% or 75 points to 18,789.40.

While attributing today's steep fall to the trends so far, V K Vijayakumar, Chief Strategist, , said that if BJP doesn’t get a majority on its own, there will be disappointment and this is getting reflected in the market.

However he sees positive trade in the FMCG stock for a different reason. "It is possible that Modi 3.0 may not be as as the market expected and may turn more welfare- oriented. This is reflected in the strength in ," Vijayakumar said.

N Jayakumar, Managing Director at , sees big opportunities in the pharma sector. "The biggest reason being the sectoral weight that pharma enjoys is still to my mind under 6%. Number two, most of the stocks there represent under-ownership, reasonably high promoter ownership, and participation still is low," he reasoned.

Also Read:

(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
Poll Trackers

Source: Stocks-Markets-Economic Times

Останні публікації
Oklo target nearly doubled at Wedbush on AI-driven demand for nuclear energy
24.01.2025 - 18:00
Crypto markets lose steam after Trump's first policy move
24.01.2025 - 18:00
Combination of Google's TPU-DeepMind units may be worth $700 bn - DA Davidson
24.01.2025 - 18:00
British American Tobacco, Altria shares rise after menthol ban proposal dropped
24.01.2025 - 18:00
Morocco stocks higher at close of trade; Moroccan All Shares up 0.34%
24.01.2025 - 18:00
Commerzbank says no talks with UniCredit until specific proposal made
24.01.2025 - 18:00
Venture Global aims for $64 billion valuation at debut in test for energy IPOs
24.01.2025 - 18:00
Intuitive Machines stock surges on NASA contract award
24.01.2025 - 18:00
International Paper's $7.2 billion acquisition of DS Smith gets EU approval
24.01.2025 - 18:00
Short-term stock optimism soars among retail investors, AAII survey shows
24.01.2025 - 18:00
Venture Global shares likely to open up to 6% above IPO price
24.01.2025 - 18:00
Intuitive Surgical, American Express Stir Friday's Market Cap Stock Movers
24.01.2025 - 18:00
BMW joins Chinese EV makers in filing EU court challenge to tariffs
24.01.2025 - 18:00
Turkey stocks lower at close of trade; BIST 100 down 0.08%
24.01.2025 - 18:00
Diageo stock jumps on possible Guinness sale
24.01.2025 - 18:00

© Analytic DC. All Rights Reserved.

new
Аналіз ринку Як вплине завтра звіт NFP на курс долара США?